SARITUS-CPM Suspension combines Levocloperastine Fendizoate 35.4 mg equivalent to Levocloperastine HCl 20 mg with Chlorpheniramine Maleate 4 mg per 5 mL. It is formulated for symptomatic relief of dry cough and associated allergic symptoms under healthcare-professional guidance.